{"id":247716,"date":"2026-11-18T23:09:16","date_gmt":"2026-11-19T05:09:16","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/11\/blood-test-may-reveal-which-lymphoma-patients-will-respond-to-immunotherapy"},"modified":"2026-11-18T23:09:16","modified_gmt":"2026-11-19T05:09:16","slug":"blood-test-may-reveal-which-lymphoma-patients-will-respond-to-immunotherapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/11\/blood-test-may-reveal-which-lymphoma-patients-will-respond-to-immunotherapy","title":{"rendered":"Blood test may reveal which lymphoma patients will respond to immunotherapy"},"content":{"rendered":"\n<p>Cornell engineers and Dana-Farber oncologists found that RNA floating in the plasma carries a signature of a lymphoma tumor\u2019s surroundings, one that tracked with whether patients were still in remission a year later.<\/p>\n<p>Of 91 lymphoma patients who received a powerful cell therapy at Dana-Farber Cancer Institute, those whose blood carried a particular gene expression signature before treatment were far less likely to see their cancer progress. Patients with high scores on that signature had an 80% lower risk of progression than those with low scores, according to a new study from Cornell and Dana-Farber. The <a href=\"https:\/\/www.cell.com\/cell-reports-medicine\/fulltext\/S2666-3791(26)00593-8\" target=\"_blank\">research was published Nov. 18<\/a> in the journal Cell Reports Medicine.<\/p>\n<p>The genetic signature comes from cell-free RNA, fragments of genetic material shed by cells into the bloodstream. The researchers say it offers a glimpse of the tumor\u2019s local environment without the need for a biopsy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cornell engineers and Dana-Farber oncologists found that RNA floating in the plasma carries a signature of a lymphoma tumor\u2019s surroundings, one that tracked with whether patients were still in remission a year later. Of 91 lymphoma patients who received a powerful cell therapy at Dana-Farber Cancer Institute, those whose blood carried a particular gene expression [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-247716","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/247716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=247716"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/247716\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=247716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=247716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=247716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}